Results 1 to 10 of about 57,245 (262)

Malaria genotyping for epidemiologic surveillance [PDF]

Proceedings of the National Academy of Sciences of the United States of America, 2015
Malaria control and elimination have, for more than a century, relied on traditional surveillance methods: catching mosquitoes or examining blood slides under a light microscope. Recent technological advances have started to change the game, including high-quality rapid diagnostic tests for malaria.
Bryan Greenhouse, , Smith David L
exaly   +5 more sources

Epidemiologic Surveillance in Developing Countries [PDF]

Annual Review of Public Health, 1991
developed countries in many ways. Most people are poorer, less educated, more likely to die at a young age, and less knowledgeable about factors that cause, prevent, or cure disease. Biological and physical hazards are more common, which results in greater incidence, disability, and death. Although disease is common, both the people and government have
R R Frerichs, Ralph R Frerichs
exaly   +3 more sources

Delta Variant of SARS-CoV-2 Replacement in Brazil: A National Epidemiologic Surveillance Program [PDF]

Viruses, 2022
Renato Aguiar, Aline Lima, Malta F S V   +2 more
exaly   +2 more sources

Epidemiologic surveillance for controlling Covid-19 pandemic: types, challenges and implications [PDF]

Journal of Infection and Public Health, 2020
Nahla Ibrahim
exaly   +2 more sources

Whole-Genome Analysis of Treponema pallidum Subspecies endemicum among Men Who Have Sex with Men, Japan, 2020–2023 [PDF]

Emerging Infectious Diseases
Whole-genome sequencing of Treponema pallidum subsp. endemicum strains from men who have sex with men in Japan revealed a genetically distinct lineage from other geographic regions circulating via sexual transmission.
Yuki Ohama, Kazuo Imai, Yuto Kotaka, Kenichi Lee, Ichiro Itoda, Shu-ichi Nakayama, Makoto Ohnishi, Yukihiro Akeda   +7 more
doaj   +2 more sources

Patient characteristics and pregnancy outcomes among Zika‐infected pregnant women: Epidemiologic surveillance data from two cities in Colombia, 2015–2016 [PDF]

International Journal of Gynecology and Obstetrics, 2020
Ocampo Cañas JA, Caviedes Combita D, Molina Leon HF, Garcia Sierra AM, Hernández Florez LJ.   +4 more
exaly   +2 more sources

Genomics and epidemiological surveillance [PDF]

Nature Reviews Microbiology, 2020
This month’s Genome Watch highlights how genomic surveillance can provide important information for identifying and tracking emerging pathogens such as SARS-CoV-2.
Lo, Stephanie W., Jamrozy, Dorota
openaire   +2 more sources

Replacement of SARS-CoV-2 strains with variants carrying N501Y and L452R mutations in Japan: an epidemiological surveillance assessment

Western Pacific Surveillance and Response, 2022
Objective: Monitoring the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants is important due to concerns regarding infectivity, transmissibility, immune evasion and disease severity.
Yusuke Kobayashi, Takeshi Arashiro, Miyako Otsuka, Yuuki Tsuchihashi, Takuri Takahashi, Yuzo Arima, Yura K Ko, Kanako Otani, Masato Yamauchi, Taro Kamigaki, Tomoko Morita-Ishihara, Hiromizu Takahashi, Sana Uchikoba, Michitsugu Shimatani, Nozomi Takeshita, Motoi Suzuki, Makoto Ohnishi   +16 more
doaj   +1 more source

Impact of Refutational Two-Sided Messages on Attitudes Toward Novel Vaccines Against Emerging Infectious Diseases During the COVID-19 Pandemic

Frontiers in Public Health, 2022
Two-sided messages that include two perspectives (i.e., risks and benefits) are more effective than one-sided messages that convey only one perspective (usually only the benefits).
Hideo Okuno, Hideo Okuno, Satoru Arai, Motoi Suzuki, Toshiko Kikkawa   +4 more
doaj   +1 more source

Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis

BMJ Open, 2023
Objectives The rapid spread of the SARS-CoV-2 Omicron variant has raised concerns regarding waning vaccine-induced immunity and durability. We evaluated protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant and ...
Daisuke Yoneoka, Taro Kamigaki, Erika Ota, Rei Haruyama, Moe Moe Thandar, Motoi Suzuki, Md. Obaidur Rahman, Fangyu Yan, Miho Shibamura-Fujiogi, July Khin Maung Soe, Md. Rafiqul Islam, Reiko Miyahara   +11 more
doaj   +1 more source